Lilly Reports First-Quarter 2024 Financial Results and Raises Full-Year Revenue Guidance by $2 Billion, Highlights Pipeline Momentum
Eli Lilly and Company announced its financial results for the first quarter of 2024.
Eli Lilly and Company announced its financial results for the first quarter of 2024.
HanAll Biopharma achieved 18.4 percent revenue growth in the first quarter compared to the same period last year, recording a revenue of 34.1 billion Korean Won, driven by continued strong sales across key products.
HanAll Biopharma Reports Q1 2024 Financial Results and Provides Business Update Read More »
Preparations for the planned phase 2b study continue according to plan after the completed Type C meeting with the FDA, strengthened by the fact that the median time to progression with fostrox + Lenvima increased to 7 months.
Medivir AB – Interim Report January – March 2024 Read More »
Innovent Biologics, Inc., a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, cardiovascular and metabolic, autoimmune, ophthalmology and other major diseases, announces the appointment of Dr. Samuel Zhang as its Global Chief Business Officer.
Bayer and the German-based life science company, Evotec, announced that they have updated the focus of their strategic collaboration to developing innovative precision treatments for cardiovascular diseases.
Bayer and Evotec Collaborate to Advance Precision Cardiology – April 30, 2024 Read More »
La convivencia con una persona tóxica puede tener un impacto significativo en nuestra salud mental y bienestar emocional. Ya sea en el ámbito laboral, familiar o social, lidiar con comportamientos tóxicos puede generar estrés, ansiedad y conflicto interpersonal. Conozcamo …
TFF Pharmaceuticals, Inc announced the pricing of a public offering of an aggregate of 1,665,219 shares of its common stock and warrants to purchase up to 1,665,219 shares of common stock at a combined public offering price of $2.875 per share and accompanying warrant.
TFF Pharmaceuticals Announces Pricing of $4.8 Million Public Offering Read More »
Mustang Bio, Inc. announced the pricing of a public offering of an aggregate of 16,877,638 shares of its common stock, Series A-1 warrants to purchase up to 16,877,638 shares of common stock, Series A-2 warrants to purchase up to 16,877,638 shares of common stock and Series A-3 warrants to purchase up to 16,877,638 shares of
Mustang Bio Announces Pricing of $4 Million Public Offering Read More »
En el campo de la meteorología y la ciencia atmosférica, el nombre de Vilhelm Bjerknes brilla con una luminosidad perdurable. Conocido como el “Padre de la Meteorología Moderna”, Bjerknes fue un pionero visionario cuyos descubrimientos y teorías sentaron las bas …
Vilhelm Bjerknes: El padre de la meteorología moderna Read More »
En la era digital, la generación electrónica de sonido ha revolucionado la forma en que experimentamos y creamos música, desde sintetizadores y samplers hasta software de producción musical. Pero, ¿cómo se generan realmente estos sonidos electrónicos? …
Principios fundamentales de la generación electrónica de sonido Read More »